Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v2-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2018-05-05 | 2018-04-19 |
| Drug Identification Number | 02361043 | 02361043 |
| Brand name | DIGIFAB | DIGIFAB |
| Common or Proper name | Digoxin Immune Fab (Ovine) | Digoxin Immune Fab (Ovine) |
| Company Name | BTG INTERNATIONAL INC | BTG INTERNATIONAL INC |
| Ingredients | DIGOXIN IMMUNE FAB | DIGOXIN IMMUNE FAB |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | One vial | One vial |
| ATC code | V03AB | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2018-04-13 | 2018-04-13 |
| Estimated end date | 2018-05-04 | |
| Actual end date | 2018-05-04 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Stock released for distribution 04-May-18 | Stock is available at the distributor and it is expected that further stock will be imported within 1-2 weeks |
| Health Canada comments |